You are here: Industry Insights > Enzyme

News List

MetGen Earns Acclaim from Frost & Sullivan for its Unique, Customized Enzyme Technologies, METNIN™ and ENZINE® En-CPhI.CN
October 17, 2019
Based on its recent analysis of the European industrial enzymes market, Frost & Sullivan recognizes Finland-based MetGen with the 2019 European Technology Innovation Award for its enzyme technologies...
Capsosomes: the revolutionary enzyme carriers europeanpharmaceuticalreview
July 05, 2019
Capsosomes: the revolutionary enzyme carriers.
Researchers identify enzyme that suppresses immune system in breast cancer worldpharmanews
June 20, 2019
Researchers identify enzyme that suppresses immune system in breast cancer.
Codexis, Novartis Ink Tech Transfer and License Agreement contractpharma
May 16, 2019
Novartis to leverage CodeEvolver protein engineering platform technology develop performance enzymes for use in manufacturing.
Enzyme Indicators – New technology for decontamination validation europeanpharmaceuticalreview
May 07, 2019
Enzyme Indicators – New technology for decontamination validation.
BridgIT, a new tool for orphan and novel enzyme reactions worldpharmanews
March 27, 2019
Effective protein engineering can give us control over the generated products inside a cell.
A better enzyme for CRISPR gene editing? fiercebiotech
August 03, 2018
The gene editing system CRISPR-Cas9 is promising for its potential to treat diseases caused by gene irregularities, but fears of off-target effects threaten to delay its development.
Enzyme replacement therapy to treat alpha-mannosidosis europeanpharmaceuticalreview
January 30, 2018
The EMA has recommended granting a marketing authorisation in the EU for Lamzede a long-term enzyme replacement therapy for alpha-mannosidosis…
Alzheimer's and Parkinson's spurred by same enzyme worldpharmanews
July 06, 2017
Alzheimer's disease and Parkinson's disease are not the same. They affect different regions of the brain and have distinct genetic and environmental risk factors.
New research reveals caspase-2 enzyme deficiency increases risk of developing tumours pharmaceutical-technology
January 25, 2017
Researchers from the University of South Australia at the Centre for Cancer Biology have revealed that people with a deficiency of enzyme caspase-2 are at a higher risk of developing tumours.

Previous page 1 2 3 Next page